Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2026-02-02 @ 10:08 PM
Study NCT ID:
NCT02668666
Status:
COMPLETED
Last Update Posted:
2024-07-29
First Post:
2016-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Sponsor:
Oana Danciu, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hormone Receptor Positive Malignant Neoplasm of Breast | View |
| None | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | View |
| None | Estrogen Receptor Positive Breast Cancer | View |
| None | Progesterone Receptor Positive Tumor | View |
| None | Metastatic Breast Cancer | View |